Publications by authors named "Madalena Von Hafe"

Background And Aims: Metabolic dysfunction associated steatotic liver disease (MASLD) is a metabolic liver disease and thyroid hormones (TH) may decrease liver fat and extra-hepatic fat content. We aimed to evaluate the effects of high and low dose triiodothyronine (T3) in liver and subcutaneous adipose tissue (sAT) in an animal model of Metabolic Syndrome (MS).

Methods And Results: Four groups were evaluated: 1) ZSF1 Lean (Lean-Ctrl, n = 8); 2) ZSF1 obese (rat model of MS with MASLD, MetS, n = 13); 3) ZSF1 obese supplemented with high-dose of T3 (MetS-hT3, n = 5); and 4) ZSF1 obese supplemented with a low-dose of T3 (MetS-lT3, n = 8).

View Article and Find Full Text PDF

We present a compelling case of a female infant with axillary intertrigo, presumptively caused by a streptococcal infection, successfully treated with topical antibiotics. This case highlights distinctive clinical features that aid in differentiating streptococcal intertrigo from other skin fold infections, emphasising its diagnostic and therapeutic implications. Of particular importance, this report underscores the potential for negative skin smear cultures despite an underlying streptococcal aetiology, advocating for the critical role of clinical assessment in guiding timely and effective management.

View Article and Find Full Text PDF

Obesity is among the most common chronic disorders, worldwide. It is a complex disease that reflects the interactions between environmental influences, multiple genetic allelic variants, and behavioral factors. Recent developments have also shown that biological conditions in utero play an important role in the programming of energy homeostasis systems and might have an impact on obesity and metabolic disease risk.

View Article and Find Full Text PDF

Objective: Caffeine is widely used in preterm infants to prevent or treat apnoea of prematurity. Adverse gastrointestinal effects of caffeine have not been thoroughly researched in preterm infants. With this systematic review and meta-analysis, we aim to summarise the results of trials on the gastrointestinal effects of caffeine in preterm infants.

View Article and Find Full Text PDF

Introduction: It is estimated that most people undergoing bariatric surgery are women of reproductive age; nonetheless, its effects on pregnancy outcomes are not yet fully understood.

Methods: Retrospective observational study, conducted in a tertiary center in Portugal, included participants in two groups: (1) pregnant women with a history of bariatric surgery (n = 89) and (2) pregnant women with a BMI ≥ 35 kg/m2, without previous bariatric surgery (n = 176). Data was collected from the medical files.

View Article and Find Full Text PDF

Acquired cold-induced urticaria is a rare form of physical urticaria, especially in children. The variety of clinical presentations and the low estimated prevalence contribute to its underdiagnosis. Given the associated risk of anaphylaxis, it is crucial to alert clinicians to the different forms of presentation, diagnosis, and treatment.

View Article and Find Full Text PDF

Aim: Metabolic syndrome (MetS) is associated with higher cardiovascular and metabolic risks, as well as with psychosocial disorders. Data regarding quality of life (QoL) in patients with MetS, point towards a significative association between MetS and a worse QoL. It remains unclear whether MetS components and non-alcoholic fatty liver disease (NAFLD) are associated with QoL in these individuals.

View Article and Find Full Text PDF

Prenatal diagnosis of orofacial clefts allows adequate counseling and planning for prenatal care and delivery. In 2001, two-dimensional ultrasound screening became universally used in Portugal by government guidelines, and after 2007 more advanced ultrasound became available. This study aimed to describe the prevalence of family history in patients with orofacial clefts and analyze prenatal diagnosis in patients born before 2001, between 2001 and 2007 and after 2007.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with heart failure with preserved ejection fraction (HFpEF) often have thyroid dysfunction, which may be linked to worsened heart health due to reduced conversion of thyroid hormones.
  • A study on 74 stable HFpEF patients found that a lower FT3/FT4 ratio was associated with increased body fat, higher pulmonary arterial pressure, and lower left ventricular function.
  • The results indicated that a lower FT3/FT4 ratio predicts a greater risk of adverse heart-related outcomes, highlighting its potential as a prognostic marker in HFpEF patients.
View Article and Find Full Text PDF
Article Synopsis
  • Low levels of triiodothyronine (T3) are prevalent in heart failure (HF) patients, and this study aimed to assess the effects of low and replacement doses of T3 in a rat model of HF with preserved ejection fraction (HFpEF).
  • Four groups were evaluated: lean control rats, obese rats with HFpEF, and two groups of obese rats treated with either low or replacement doses of T3, administered via drinking water over 11 weeks.
  • Results indicated that T3 treatment improved metabolic profiles and cardiac function, with the high T3 dose restoring myocardial T3 levels and yielding benefits in calcium handling and heart function, despite no change in overall exercise capacity (VOmax).
View Article and Find Full Text PDF

Cerebral venous sinus thrombosis in children is a rare complication of acute mastoiditis that can potentially be fatal. Clinical expertise is essential for early diagnosis and management due to its subtle course. We present the first known case of paediatric acute mastoiditis with venous sinus thrombosis caused by and .

View Article and Find Full Text PDF

Background: Thyroid hormones are important modulators of cardiovascular function. Both hypothyroidism and hyperthyroidism are known to contribute to an increased cardiovascular risk. It remains uncertain whether thyroid hormones level within the euthyroid range are associated with cardiometabolic risk.

View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine dysfunction may play an important role in NAFLD development, progression, and severity.

View Article and Find Full Text PDF

Background: Thyroid hormones (TH) are crucial for cardiovascular homeostasis. Recent evidence suggests that acute cardiovascular conditions, particularly acute heart failure (AHF), significantly impair the thyroid axis. Our aim was to evaluate the association of thyroid function with cardiovascular parameters and short- and long-term clinical outcomes in AHF patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Conducted between 2010 and 2018, the study included 1,124 patients, revealing that a significant portion had low vitamin D levels, linked to higher body measurements and health risks like hypertension.
  • * Results suggest that low vitamin D is associated with a higher risk of liver fat accumulation, implying that improving vitamin D levels could aid in managing non-alcoholic fatty liver disease in these individuals.
View Article and Find Full Text PDF

Background: An association between hypothyroidism and the risk of Non-alcoholic Fatty Liver Disease (NAFLD) has been suggested. This association remains to be elucidated in patients with morbid obesity.

Aim: To evaluate the association between thyroid function and parameters of liver function and hepatic scores in patients with morbid obesity.

View Article and Find Full Text PDF

Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is common in heart failure (HF) and is associated with worse prognosis. In this review, we discuss the cardiovascular effects of thyroid hormones, the pathophysiology of HFpEF, the prognostic impact of thyroid function, and the potential of thyroid hormones for treatment of HFpEF.

View Article and Find Full Text PDF

Aims: Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in Western countries and a common comorbidity with type 2 diabetes (T2D). It lacks effective pharmacotherapy. We aimed to summarize the evidence on the effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on liver structure and function.

View Article and Find Full Text PDF

Purpose: Nonalcoholic fatty liver disease is increasingly recognized as the hepatic counterpart of metabolic syndrome. It is hypothesized that structural and functional cardiac changes may be associated with this metabolic disease. We aimed to gather the existing information on the association of nonalcoholic fatty liver disease with cardiac alterations, and to evaluate a possible correlation between them.

View Article and Find Full Text PDF
Article Synopsis
  • Thyroid hormones play a crucial role in heart health by improving heart muscle function, promoting blood vessel growth, and maintaining the cellular structure around heart tissue.
  • Both overt and subclinical hypothyroidism can lead to a higher risk of heart issues like coronary events and heart failure, as they disrupt normal heart energy levels and blood flow regulation.
  • In cases of ischemic heart disease, thyroid dysfunction is common and may worsen heart conditions, suggesting that treating low thyroid levels could be a beneficial therapy for improving heart health.
View Article and Find Full Text PDF
Article Synopsis
  • - Cardiovascular diseases are the top global cause of death, with heart failure (an advanced stage of these diseases) having high rates of illness and death, particularly with heart failure that preserves ejection fraction (HFpEF) affecting 40-71% of patients.
  • - There is currently no effective treatment for HFpEF, and a notable portion of heart failure patients exhibit thyroid hormone dysfunction, which negatively impacts cardiovascular function.
  • - Research indicates that thyroid hormones might be a potential treatment for heart failure, as studies show they may improve cardiac function and are linked to worse outcomes in patients with low thyroid hormone levels; more research is needed for safety and effectiveness.
View Article and Find Full Text PDF